22^nd world congress On Pathology, Microbiology & Clinical Practice

Gilbert Glady Born in Strasbourg, France, Gilbert Glady graduated from Medical School in 1977 and was then an intern in onco-hematology at the university clinic for several years. After a specialization in homeopathy and naturopathy in Paris, he returned to the Alsace region to work as a private practitioner. Through his work and encounters, he developed interest and expertise in immunology and immunogenetics, that leaded him to nanomedicine and nanobiotechnology. He thus became in 2010 the creator of the BI(G)MED method (Bio Immune (G)ene Medicine) and director of EBMA, the European association responsible for communication and trainings in the field of BI(G) MED. He has participated in numerous international congresses in immuno-allergology, infectiology and oncology with posters and oral presentations, and is the author of several publications on nanobiotherapy in different journals

immunology, immunogenetics, Infectiology, Oncology, nanomedicine, nanobiotechnology

Ahmed El-Habashi has completed his MD, PhD from Cairo University and Tulane University in a channel system scholarship program. He got Post-doctoral fellowship at Groningen University Hospital, The Netherlands at 1998. He is the past-director of pathology department, National Cancer Institute, Cairo University and now he is working in the capacity of Professor of Pathology. He got the International Board of Cytopathology from International Academy of Cytopathology at 2007. He is an international cytology speaker and he conducted many Cytopathology workshops in Egypt and Arab countries aiming to improve the cytology practice and profession. He has published more than 35 papers in reputed journals and has been serving as a reviewer for more than three reputed Journals.

Cytopathology, Pathology

Sergey Suchkov was born in 11.01.1957, a researcher-immunologist, a clinician, graduated from Astrakhan State Medical University, Russia, in 1980. Suchkov has been trained at the Institute for Medical Enzymology, The USSR Academy of Medical Sciences, National Center for Immunology (Russia), NIH, Bethesda, USA, and British Society for Immunology to cover 4 British university facilities. Since 2005, Suchkov has been working as Professor of I.M. Sechenov First Moscow State Medical University and of A.I.Evdokimov Moscow State Medical & Dental University. From 2007, Suchkov is the First Vice-President and Dean of School of PPPM Politics and Management of the University of World Politics and Law. In 1991-1995, Suchkov was a Scientific Secretary-in-Chief of the Editorial Board of the Interna-tional Journal “Biomedical Science” (Russian Academy of Sciences and Royal Society of Chemistry, UK) and The International Publishing Bureau at the Presidium of the Russian Academy of Sciences. In 1995-2005, Suchkov was a Director of the Russian-American Program in Immunology of the Eye Diseases. Suchkov is a member of EPMA (European Association of Predictive, Preventive and Person-alized Medicine, Brussels-Bonn), a member of the NY Academy of Sciences, a member of the Editorial Boards for Open Journal of Immunology, EPMA J., and Personalized Medicine Universe, and others. Suchkov is known as a co-author of the Concept of post-infectious clinical and immunological syn-drome, co-author of a concept of abzymes and their impact into the pathogenesis of autuimmunity conditions, and as one of the pioneers in promoting the Concept of PPPM into a practical branch of health services. Now Suchkov is a Chair of Dept for Personalized & Translational Medicine, and Director, Center for Personalized & Translational Reproductology, I.M.Sechenov First Moscow State Medical University. Prof Sergey Suchkov, MD, PhD Chair, Dept for Personalized and Translational Medicine, Director, Center for Personalized Reproductology & Pediatrics, I.M.Sechenov First Moscow State Medical University, Moscow, Russia Member, EPMA, Brussels, EU Member, PMC, Washington, DC, USA Member, ISPM, Tokyo, Japan Member, New York Academy of Sciences Member, ACS, USA Member, AHA, USA Member, AMEE, Dundee, UK Secretary General, UCC, Cambridge, UK

Translational Medicine

El Hadji Seydou Mbaye was born in 1978 in Kaolack a region of Senegal. During 2008-2013, he earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer (IARC) /WHO, Lyon (France). He was certified by the Federation International of Gynecology Obstetrics (FIGO), the Accreditation Council of Oncology in Europe (ACOE, www.acoe.be), the Institute Catalan of Oncology (ICO) for cervical cancer prevention (Grade 10/10) in support of Continuing Medical Education for physicians. These credits are also recognized as Physician’s Recognition Award (AMA PRA Category 1 credits) by the American Medical Association. He was certified, by the United Nations for Basic Notion of Security on the Ground-Protection, Health and behavior, by the International Agency for Research on Cancer (IARC)/World Health Organization, Lyon (France) for Safety Certificate. He has published 1 Book with a style of philosophical story. Author of the world program against cancer in low and middle incomes countries, he is lead author (first listed) of more than 90 peer-reviewed research articles published in reputed journals. He is a member of BCNet International Working Group, International Agency for Research on Cancer (IARC)/World Health Organization (WHO). Mbaye, has formed for free, more than 250 healthcare professionals for the techniques of cervical cancer screening in Senegal. He has appeared on local media, 2S TV, Mbour TV and Leeral.net.

Women genital sphere infections, Cancer, Viruses, Immunology, Pesticides and cancer, Microbiology, Human Bio-banking, Vaccines and Vaccination Program

Helieh S. Oz has DVM, and MS (U. IL); PhD (U. MN) and clinical translational research certificate (U. KY Med Center). Oz is an active member of American Association of Gastroenterology (AGA) and AGA Fellow (AGAF). Oz is Microbiologist scientist with expertise in infectious and inflammatory diseases, drug discoveries, pathogenesis, innate and mucosal Immunity, molecular biology, and micronutrient. Oz has over 90 publications in areas of chronic inflammatory disorders (e.g. pancreatitis, hepatitis, colitis), microbial and infectious diseases (e.g. Toxoplasmosis, Trypanosomasis, Babesiosis, Coccidiosis, Pneumocystis pneumonia). She has served as Lead editor for special issues including Gut Inflammatory, Infectious diseases and Nutrition 2017 (Mediators of Inflammation); Nutrients, Infectious and Inflammatory Diseases 2017 (Nutrients); Gastrointestinal Inflammation and Repair: Role of Microbiome, Infection, Nutrition 2016 (Gastroenterology Research Practice), and co-editor for Parasitic infections in pediatric clinical practice 2017 (J Pediatric Infectious Disease), Chagas Disease, Intech Open Science 2017 and member of different advisory committees.

Infection, Immunology of infectious disease, Innate Immunity, Microbiology

Gregory A. Buck, Ph.D., is Professor of Microbiology and Immunology at Virginia Commonwealth University. He obtained his BS in Genetics from the University of Wisconsin-Madison, and his MS and Ph.D. in Microbiology and Immunology from the University of Washington-Seattle studying the toxinogenic bacteriophages of Corynebacterium diphtheria. He did postdoctoral research at the Institut Pasteur in Paris studying the genetics of antigenic variation in African Trypanosomes, and subsequently joined the faculty in the department of Microbiology and Immunology at VCU. He founded and directs VCUs Nucleic Acids Research Facilities which maintains VCUs Next Generation Sequencing infrastructure, and Center for High Performance Computing which provides research computing capacity to VCUs investigators. He founded the Center for the Study of Biological Complexity in 2000 under the umbrella of VCU Life Sciences, and directed that unit until 2017. His recent work has focused on high throughput microbial genomics and metagenomics, with a focus on womens health.

Microbiology and Immunology